SynthesisInflammopharmacology2026
Clinical efficacy and mechanisms of krill oil supplementation in knee osteoarthritis: meta-analysis and mechanistic insights.
Synthesis in Inflammopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the clinical efficacy and safety of krill oil supplementation in patients with knee osteoarthritis (KOA) through a systematic review and meta-analysis. Potential mechanisms are discussed based on existing literature.
methodsA systematic search was performed across PubMed, Embase, Cochrane Library, and Web of Science for randomized controlled trials (RCTs) investigating krill oil supplementation in patients with KOA. Studies were selected according to pre-defined inclusion and exclusion criteria. Data were independently extracted by two reviewers and pooled using RevMan 5.4. Risk of bias was assessed with the Cochrane Risk of Bias tool.
resultsSix RCTs with 971 participants were included. Krill oil supplementation significantly improved pain and physical function (WOMAC scores at week 4), with moderate effects observed on stiffness. Krill oil significantly increased HDL-C and omega-3 levels, but had no effect on LDL-C and CRP. No significant adverse events were reported.
conclusionKrill oil is a promising functional food with a favorable safety profile for KOA symptom management, particularly for pain and physical function. The findings suggest potential mechanisms related to its anti-inflammatory and antioxidant effects, supporting its role in nutraceutical interventions for KOA.
Indexed as
Identifiers
42014647What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.